Retinitis pigmentosa: current clinical management and emerging therapies

XTA Nguyen, L Moekotte, AS Plomp… - International journal of …, 2023 - mdpi.com
Retinitis pigmentosa (RP) comprises a group of inherited retinal dystrophies characterized
by the degeneration of rod photoreceptors, followed by the degeneration of cone …

[HTML][HTML] Therapy with voretigene neparvovec. How to measure success?

K Stingl, M Kempf, R Jung, F Kortuem, G Righetti… - Progress in Retinal and …, 2023 - Elsevier
Retinal gene supplementation therapy such as the first approved one, voretigene
neparvovec, delivers a functioning copy of the missing gene enabling the protein …

Gene Editing for CEP290-Associated Retinal Degeneration

EA Pierce, TS Aleman, KT Jayasundera… - … England Journal of …, 2024 - Mass Medical Soc
Background CEP290-associated inherited retinal degeneration causes severe early-onset
vision loss due to pathogenic variants in CEP290. EDIT-101 is a clustered regularly …

Survey of perspectives of people with inherited retinal diseases on ocular gene therapy in Australia

HG Mack, AC Britten-Jones, MB McGuinness, FK Chen… - Gene Therapy, 2023 - nature.com
Many gene therapies are in development for treating people with inherited retinal diseases
(IRD). We hypothesized that potential recipients of gene therapy would have knowledge …

Functional evaluation in inherited retinal disease

MD Varela, M Georgiou, SA Hashem… - British Journal of …, 2022 - bjo.bmj.com
Functional assessments are a fundamental part of the clinical evaluation of patients with
inherited retinal diseases (IRDs). Their importance and impact have become increasingly …

Correlations between the Michigan Retinal Degeneration Questionnaire and visual function parameters in patients with retinitis pigmentosa

JS Karuntu, XT Nguyen, CJF Boon - Acta ophthalmologica, 2024 - Wiley Online Library
Purpose To validate the use of best‐corrected visual acuity (BCVA), low‐luminance visual
acuity (LLVA), low‐luminance deficit (LLD; the difference between BCVA and LLVA), mean …

Beyond the NEI-VFQ: recent experience in the development and utilization of patient-reported outcomes for inherited retinal diseases

T Durham, J Banhazi… - Cold Spring …, 2023 - perspectivesinmedicine.cshlp.org
Patient-reported outcome measures (PROMs) are tools designed to capture how a patient
feels or functions, without the input or interpretation of anyone else. The earliest PROMs …

Change in cone structure over 24 months in USH2A-related retinal degeneration

JL Duncan, W Liang, MG Maguire, TC Porco… - American Journal of …, 2023 - Elsevier
Purpose To describe cone structure changes using adaptive optics scanning laser
ophthalmoscopy (AOSLO) in the Rate of Progression of USH2A-related Retinal …

Challenges of cost-effectiveness analyses of novel therapeutics for inherited retinal diseases

KT Jayasundera, RO Abuzaitoun, GD Lacy… - American journal of …, 2022 - Elsevier
Purpose To investigate the challenges and potential improvement strategies of cost-
effectiveness analyses performed for therapeutics targeting inherited retinal diseases …

Therapeutic landscape for inherited ocular diseases: Current and emerging therapies

HW Chan, J Oh, B Leroy - Singapore medical journal, 2023 - journals.lww.com
Inherited ocular diseases comprise a heterogeneous group of rare and complex diseases,
including inherited retinal diseases (IRDs) and inherited optic neuropathies. Recent success …